Covalon Technologies Ltd (COV_CDNX)
COV_CDNX moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How COV_CDNX actually reacts to news — the realized, point-in-time move the market made, measured across 65 labeled events over the last three years with zero look-ahead.
COV_CDNX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 13% | 15 |
| 30-min | 0.00% | 27% | 15 |
| 60-min | 0.00% | 27% | 15 |
| to close | 0.00% | 33% | 15 |
| Middle 50% of COV_CDNX reactions | 0.00% to +1.96% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 65 |
Half of all Covalon Technologies Ltd news events land between +0.00% and +1.96% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when COV_CDNX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to COV_CDNX's baseline. Nothing else.
Recent COV_CDNX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Contamination Protection Solution Highlights Covalon’s Presence at the Association for Vascular Access 2026 Annual Scientific Meeting | Press release | Business Wire | — | — | |
| Covalon Reports Encouraging Findings From Real World Evidence Analysis Comparing Collagen Dressings | Press release | Business Wire | — | — | |
| Covalon to Present at the 2026 Annual Smallcap Discoveries Conference After Reporting Revenue Growth of 20% and Gross Margin of 67% | Press release | Business Wire | — | — | |
| Covalon Reports Fiscal 2026 Third Quarter Results | Press release | Business Wire | — | — | |
| Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2026 Results | Press release | Business Wire | — | — | |
| Covalon Announces Appointment of New Director and DSU Grants | Press release | Business Wire | — | — | |
| Covalon Reports 2026 Second Quarter Results | Press release | Business Wire | — | — | |
| Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2026 Results | Press release | Business Wire | — | — | |
| Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care | Press release | Business Wire | — | — | |
| Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting | Press release | Business Wire | — | — | |
| Covalon Announces Grant of Deferred Share Units | Press release | Business Wire | — | — | |
| Covalon Announces Voting Results from Fiscal 2025 Annual General and Special Meeting of Shareholders | Press release | Business Wire | — | — | |
| Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 25, 2026 | Press release | Business Wire | — | — | |
| Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights | Press release | Business Wire | — | — | |
| Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results | Press release | Business Wire | — | — | |
| Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications | Press release | Business Wire | — | — | |
| Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth | Press release | Business Wire | — | — | |
| Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results | Press release | Business Wire | — | — | |
| Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength | Press release | Business Wire | — | — | |
| Covalon Declares First Ever Special Cash Dividend | Press release | Business Wire | — | — | |
| Covalon to Participate in the Planet MicroCap Showcase: TORONTO on October 22, 2025 | Press release | Business Wire | — | — | |
| Empowering Nurses with Innovation: Covalon Showcases Patient Safety Solutions to Tackle Preventable Complications at ANCC National Magnet & Pathway Conference | Press release | Business Wire | — | — | |
| Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON | Press release | Business Wire | — | — | |
| Covalon Announces Departure of Executive Chair and the Appointment of its Largest Shareholder as New Chair | Press release | Business Wire | — | — | |
| Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon’s Presence at the Association for Vascular Access 2025 Annual Meeting | Press release | Business Wire | — | — | |
| Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs) | Press release | Business Wire | — | — | |
| Covalon Reports Strong Sequential Quarter on Quarter and Trailing Twelve Months Performance | Press release | Business Wire | — | — | |
| Covalon Technologies Ltd. Achieves DTC Eligibility in the United States | Press release | Business Wire | — | — | |
| Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2025 Financial Results | Press release | Business Wire | — | — | |
| Covalon Reports Fifth Consecutive Quarter of Positive Earnings | Press release | Business Wire | — | — | |
| Covalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line Guard | Press release | Business Wire | — | — | |
| Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2025 Financial Results | Press release | Business Wire | — | — | |
| Covalon Retains Financial and Strategic Advisor to Advise on Shareholder Value-Enhancing Opportunities | Press release | Business Wire | — | — | |
| Covalon Announces Promotion of Kim Crooks to Chief Operating Officer and Appointment to Board of Directors | Press release | Business Wire | — | — | |
| Covalon to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, May 6, 2025 | Press release | Business Wire | — | — | |
| Covalon to Present at the Planet MicroCap Showcase: VEGAS on April 23, 2025 | Press release | Business Wire | — | — | |
| Covalon Technologies Ltd. Poised for Strong Benefit From Positive US Tariff Outcome | Press release | Business Wire | — | — | |
| Covalon Announces Voting Results from Fiscal 2024 Annual Meeting of Shareholders | Press release | Business Wire | — | — | |
| Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 19, 2025 | Press release | Business Wire | — | — | |
| Covalon Reports Fourth Consecutive Quarter of Year over Year Revenue Growth and Positive Earnings | Press release | Business Wire | — | — | |
| Covalon Technologies Ltd. Named as a TSX Venture Exchange 2025 Top 50 Company | Press release | Business Wire | — | — | |
| Covalon Announces Conference Call to Discuss First Quarter Fiscal 2025 Financial Results | Press release | Business Wire | — | — | |
| Covalon Technologies Ltd. Selected as a 2025 OTCQX Best 50 Company | Press release | Business Wire | — | — | |
| Covalon Technologies Releases Statement on United States – Canada Trade Dispute | Press release | Business Wire | — | — | |
| Covalon Announces Strong Fourth Quarter and Year End Fiscal 2024 Results | Press release | Business Wire | — | — | |
| Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2024 Financial Results | Press release | Business Wire | — | — | |
| Covalon Technologies Highlights Compassionate Care Technologies at 2024 ANCC National Magnet Conference | Press release | Business Wire | — | — | |
| Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting | Press release | Business Wire | -1.47% | +0.00% | |
| Covalon Announces Successful Warrant Redemption from 2019 Private Placement | Press release | Business Wire | -1.51% | -3.03% | |
| Covalon to Present at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024 at 10:00 a.m. PST | Press release | Accesswire | +0.30% | -1.81% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the COV_CDNX section they belong to.
Where else COV_CDNX is measured.
COV_CDNX earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SIRONA BIOCHEM CORP ORD (SRBCF) | 66 | 0.00% | 22% |
| VASO CORPORATION (VASO) | 66 | +0.71% | 57% |
| EMERGENT HEALTH CORP (EMGE) | 65 | 0.00% | 33% |
| EASTGATE BIOTECH CORP (ETBI) | 65 | 0.00% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Covalon Technologies Ltd's median reaction calculated?
Every labeled COV_CDNX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 65 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 27% of COV_CDNX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does COV_CDNX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.